# A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency

> **NCT00400842** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 274 (actual)

## Conditions studied

- Exocrine Pancreatic Insufficiency, Chronic Pancreatitis

## Interventions

- **DRUG:** SA-001
- **DRUG:** SA-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00400842
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 274 (ACTUAL)
- **Last updated:** 2011-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00400842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00400842, "A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00400842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*